Prosecution Insights
Prosecution Insights
5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 2 (40%) |
| No statute on record | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SEITZ, ANTHONY JOSEPH | 1 | 68.8% | +28.3% |
| TOWNSLEY, SARA ELIZABETH | 1 | 25.3% | +48.6% |
| NOTTINGHAM, KYLE GREGORY | 1 | 60.8% | +33.8% |
| JOHANNSEN, DIANA B | 1 | 53.2% | +41.1% |
| XIAO, YAN | 1 | 67.9% | +51.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18229662 | QUINAZOLINE PAN-KRas INHIBITORS | TOWNSLEY, SARA ELIZABETH | 9d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18286961 | KRAS G12C INHIBITORS | SEITZ, ANTHONY JOSEPH | 49d overdue |
| 18026799 | COMBINATION THERAPIES | XIAO, YAN | 7d |
| 18229662 | QUINAZOLINE PAN-KRas INHIBITORS | TOWNSLEY, SARA ELIZABETH | 9d |
| 18274441 | COMBINATION THERAPIES | NOTTINGHAM, KYLE GREGORY | 12d |
| 18032492 | METHODS FOR TREATMENT OF LUNG CANCERS | JOHANNSEN, DIANA B | 40d |
| Art Unit | Apps |
|---|---|
| 1629 | 2 |
| 1621 | 1 |
| 1682 | 1 |
| 1642 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18286961 | KRAS G12C INHIBITORS | SEITZ, ANTHONY JOSEPH | 1629 | Other | Non-Final OA | 49d overdue | Pending | Oct 13, 2023 |
| 18229662 | QUINAZOLINE PAN-KRas INHIBITORS | TOWNSLEY, SARA ELIZABETH | 1629 | Other | Non-Final OA | 9d | Pending | Aug 02, 2023 |
| 18274441 | COMBINATION THERAPIES | NOTTINGHAM, KYLE GREGORY | 1621 | Other | Non-Final OA | 12d | Pending | Jul 26, 2023 |
| 18032492 | METHODS FOR TREATMENT OF LUNG CANCERS | JOHANNSEN, DIANA B | 1682 | §102 | Final Rejection | 40d | Pending | Apr 18, 2023 |
| 18026799 | COMBINATION THERAPIES | XIAO, YAN | 1642 | §102 | Non-Final OA | 7d | Pending | Mar 16, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial